Found: 484
Select item for more details and to access through your institution.
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 877, doi. 10.1007/s10637-018-0582-0
- By:
- Publication type:
- Article
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 4, p. 413, doi. 10.1002/ajh.25726
- By:
- Publication type:
- Article
Relapsed or refractory nongastric marginal zone B-cell lymphoma: Multicenter retrospective analysis of 92 cases.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 12, p. 826, doi. 10.1002/ajh.21557
- By:
- Publication type:
- Article
Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: a prospective multicenter study.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/245247
- By:
- Publication type:
- Article
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 325, doi. 10.4143/crt.2022.008
- By:
- Publication type:
- Article
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30--Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 2, p. 374, doi. 10.4143/crt.2019.198
- By:
- Publication type:
- Article
Body Cavity–Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1302, doi. 10.4143/crt.2018.555
- By:
- Publication type:
- Article
Rapid Emergence and Clonal Dissemination of CTX-M-15-Producing Salmonella enterica Serotype Virchow, South Korea.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Primary Thyroid Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type: Clinical Manifestation and Outcome of a Rare Disease - Consortium for Improving Survival of Lymphoma Study.
- Published in:
- Acta Haematologica, 2012, v. 127, n. 2, p. 100, doi. 10.1159/000333113
- By:
- Publication type:
- Article
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry.
- Published in:
- Acta Haematologica, 2009, v. 122, n. 4, p. 200, doi. 10.1159/000253027
- By:
- Publication type:
- Article
A prognostic Scoring System for Patients With Multiple Myeloma Who Were Classified Stage II by Revised International Staging System.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e39, doi. 10.1016/j.clml.2017.03.068
- By:
- Publication type:
- Article
Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-68310-w
- By:
- Publication type:
- Article
A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 707, doi. 10.1111/bjh.14701
- By:
- Publication type:
- Article
Report of Aids-related Lymphoma in South Korea.
- Published in:
- Japanese Journal of Clinical Oncology, 2008, v. 38, n. 2, p. 134
- By:
- Publication type:
- Article
Clinical outcomes and prognostic factors inpatients with breast diffuse large B cell lymphoma;Consortium for Improving Survival of Lymphoma(CISL) study.
- Published in:
- BMC Cancer, 2010, v. 10, p. 321, doi. 10.1186/1471-2407-10-321
- By:
- Publication type:
- Article
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2192, doi. 10.3390/cancers12082192
- By:
- Publication type:
- Article
Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 9, p. 4969, doi. 10.1007/s00520-021-06017-y
- By:
- Publication type:
- Article
Prevalence of Isolated Nocturnal Hypertension and Development of Arterial Stiffness, Left Ventricular Hypertrophy, and Silent Cerebrovascular Lesions: The KoGES (Korean Genome and Epidemiology Study).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Identification of Markers Associated With Development of Stroke in "Clinically Low-Risk" Atrial Fibrillation Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 5, p. 539, doi. 10.1007/s00277-010-1104-0
- By:
- Publication type:
- Article
Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 1, p. 235, doi. 10.1002/ijc.26352
- By:
- Publication type:
- Article
Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.
- Published in:
- Cancer Science, 2010, v. 101, n. 11, p. 2443, doi. 10.1111/j.1349-7006.2010.01698.x
- By:
- Publication type:
- Article
Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3615, doi. 10.1007/s00277-024-05907-5
- By:
- Publication type:
- Article
The Effect of the Lacticaseibacillus paracasei BEPC22 and Lactiplantibacillus plantarum BELP53 Combination (BN-202M) on Body Fat Percentage Loss in Overweight Individuals: A Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- Nutrients, 2024, v. 16, n. 13, p. 1, doi. 10.3390/nu16131993
- By:
- Publication type:
- Article
A Robust 3D Cage‐like Ultramicroporous Network Structure with High Gas‐Uptake Capacity.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 13, p. 3473, doi. 10.1002/ange.201800218
- By:
- Publication type:
- Article
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1472, doi. 10.1007/s10637-020-00916-3
- By:
- Publication type:
- Article
Integrated copy number and gene expression profiling analysis of epstein-barr virus-positive diffuse large b-cell lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 6, p. 383, doi. 10.1002/gcc.22249
- By:
- Publication type:
- Article
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1757, doi. 10.1002/ajh.27413
- By:
- Publication type:
- Article
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 12, p. 1280, doi. 10.1002/ajh.24891
- By:
- Publication type:
- Article
Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 751, doi. 10.1002/ajh.23731
- By:
- Publication type:
- Article
Clinical features and treatment outcome of primary systemic light-chain amyloidosis in Korea: Results of multicenter analysis.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 1, p. 52, doi. 10.1002/ajh.23333
- By:
- Publication type:
- Article
The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 9, p. 937, doi. 10.1002/ajh.23267
- By:
- Publication type:
- Article
Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 663, doi. 10.1002/ajh.23213
- By:
- Publication type:
- Article
Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 5, p. 479, doi. 10.1002/ajh.23150
- By:
- Publication type:
- Article
Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 5, p. 362, doi. 10.1002/ajh.21663
- By:
- Publication type:
- Article
Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia (Presented in part at the 29<sup>th</sup> World Congress of the International Society of Hematology, August 2428, 2002, Seoul, Korea).
- Published in:
- American Journal of Hematology, 2003, v. 73, n. 4, p. 263, doi. 10.1002/ajh.10363
- By:
- Publication type:
- Article
Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.
- Published in:
- Cancer Communications, 2021, v. 41, n. 3, p. 275, doi. 10.1002/cac2.12150
- By:
- Publication type:
- Article
Comparison of the freiburg and charlson comorbidity indices in predicting overall survival in elderly patients with newly diagnosed multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Clinical factors associated with response or survival after chemotherapy in patients with waldenström macroglobulinemia in Korea.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/437852
- By:
- Publication type:
- Article
Clinical Factors Associated with Response or Survival after Chemotherapy in Patients with Waldenström Macroglobulinemia in Korea.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/253243
- By:
- Publication type:
- Article
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1139980
- By:
- Publication type:
- Article